Re-Cycling Em 01/18/2009
The world’s biggest drug maker is cleaning out its chemical compound closet and firing 800 researchers, or 8 percent of its science staff, as it focuses on developing medicines to treat cancer, brain disorders and pain, said Martin MacKay, the New York-based company’s research chief, at the J.P. Morgan Healthcare Conference in San Francisco today. Some compounds Pfizer wants to sell have been tested on humans, MacKay said. CommentsLeave a Reply |
RSS Feed